Does everyone have digestive issues? — Gut dysbiosis is on the rise.
In this article we discuss the rise in gut dysbiosis, and new risk factors: microplastics, consumption of supplements, and chronic stress.
Nutraceuticals
Models to Research Microbiome
In this article, we will discuss the commonly used model organisms for microbiome research, and what insights they can provide.
Nutraceuticals and the Genomic Revolution [White Paper]
In this white paper, we discuss how you can leverage scientific studies to increase your customer confidence, attract new investments, develop new products, and protect your intellectual property (IP).
How Genomic Advancements are Fueling Innovation in Nutraceuticals [Webinar]
Join InVivo Biosystems and Faraaz Jamal, CEO of Mikra, to hear how genomic advances are fueling nutraceutical innovations
Nutraceuticals & New approaches to DMD treatment
This article will discuss recent findings, and how similar studies present an exciting and promising future for currently incurable diseases.
Why Turmeric? Separating the Credible from the Con
Turmeric has become a buzzword in the health community, its market size growing immensely in the past few years: approximately doubling from $50.3 million in 2017 to $97 million in 2020, and is expected to continue this growth, jumping to $191.89 million by 2028 (Grand View Research, 2021; Schultz, 2021). But what separates turmeric from other health fads like the routinely debunked ‘celery juice detox’ trend?